200

Home > Blog > 200

Tag: 200

200pm

By

The Role of Social Media in Suicide Risk Assessment

Speaker(s):

Anchana Dominic, MD

Presentation:

According to the World Health Organization, an estimated 800,000 people died in 2016 due to suicide. In this era of technological advances, social media’s role in suicide and suicide prevention has often been questioned. Highly publicized media reports of celebrity suicide and TV shows romanticizing the topic may also have effects on subsequent trends in suicide rates among the general population. Data suggests that social media may have a negative impact on mental health through cyber-bullying of vulnerable individuals and by promoting comparative feelings of inadequacy. However, harnessing the unique strengths of social media can contribute to the spread and reach of suicide prevention efforts among users.

Social media platforms can encourage suicide prevention by identifying individuals who are at acute risk of suicide, reaching them anonymously and providing them with resources. It can also spread mental health awareness of appropriate prevention efforts and treatment interventions.

In this presentation, the impact of social media on mental health and recent trends in suicide rates will be teased out. The assessment of suicidal risk by identifying specific tell signs of acute suicidal ideation as expressed through social media will be discussed. How to effectively use social media as a suicide intervention tool and promotion of mental health will also be discussed.

Objectives:

  1. Identify ways different social media platforms can be used to promote suicide prevention
  2. Discuss the link between media reports on suicide and subsequent trends in suicide rates
  3. Identify ways social media can identify, reach, or promote seeking treatment among individuals at risk of suicide

Slides and Handouts:

 

By

Methamphetamine Use Disorder: A Review of the Pharmacologic Treatment

Speaker(s):

Melissa Palmer, PharmD, BCPS, BCPP

Presentation:

Methamphetamine use disorder has no current FDA-approved medications for treatment, although it is an increasingly prevalent concern. In 2016, the National Survey on Drug Use and Health reported that there were 684,000 people ages 12 and older with a methamphetamine use disorder. Data from the Substance Abuse and Mental Health Services Administration reported that treatment for methamphetamine use increased by 52% from 2012 to 2016. Several medications have been studied in an off-label manner, although the 2015 VA/DoD Clinical Practice Guidelines for the Management of Substance Use Disorders has opined that there is insufficient evidence to recommend for or against the use of any pharmacologic agents for methamphetamine use. Medications that have been researched include disulfiram, topiramate, modafinil, bupropion, agonist replacement, and baclofen. Evidence supporting the use of these agents will be reviewed and discussed, including application to clinical care.

Objectives:

  1. Compare and contrast pharmacologic agents used in the treatment of methamphetamine use disorder.
  2. Identify patients who could benefit from medication therapy.
  3. Develop a patient-centered treatment plan considering patient-specific factors such as co-morbidities and socioeconomic parameters.

Slides and Handouts:

PALMER_Methamphetamine Use Disorder 5.6

By

Dominic, Anchana, MD

Dr. Anchana Dominic is originally from St. Louis, Missouri. She attended a combined program at University of Missouri-Kansas City where she earned a Bachelors in Liberal Arts and her medical degree. She is currently a psychiatry resident at MU HealthCare and works at Missouri Psychiatric Center in Columbia, Missouri. Dr. Dominic’s interests are in forensic psychiatry and addiction medicine. In her free time, she enjoys traveling, running, and spending time with her friends and family. 

Presentation(s): 

The Role of Social Media in Suicide Risk Assessment 

 

 

By

Autism and Mental Health

Speaker(s):

Beth Orns, MSW, LCSW

Presentation:

This presentation will look at autism and the mental health issues that most commonly occur with autism.  We will look at what these issues look like using diagnostic criteria as well as real case examples. Participants will learn about evidence based approaches to treating individuals with co-occurring autism and mental health issues.  Participants will also learn about resources and techniques that they can incorporate in any setting to support clients who are neuro-diverse.  


Objectives:

  1. Define the diagnostic criteria of autism

  2. Define the diagnostic criteria of mental health issues that commonly co-occur with autism

  3. Understand ways to support clients who have co-occurring issues in the community and in an inpatient setting

  4. Understand evidence based treatment approaches for treating mental health issues that co-occur with autism

Slides and Handouts:

ORNS_BETH_Autism and Mental Health for SI_FINAL

By

Hartenstein, Jaimee, MS, PhD

Jaimee L. Hartenstein is an assistant professor in Child and Family Development at the University of Central Missouri. She currently serves as both the undergraduate and graduate program coordinator. She is a Certified Family Life Educator. Hartenstein received her Bachelor of Science degree in Human Ecology and Mass Communications and her Master’s and Ph.D in Family Studies from Kansas State University. Her primary research interest is divorce and child custody.  

Presentation(s): 

Trans and Gender Variant, Identity Development and Adverse Childhood Experiences


 

 

By

Palmer, Melissa, PharmD, BCPS, BCPP


Melissa C. Palmer, PharmD, BCPS, BCPP, is a Clinical Assistant Professor at the University of Missouri-Kansas (UMKC) City School of Pharmacy. Dr. Palmer received her Doctor of Pharmacy degree from UMKC School of Pharmacy. She completed a PGY-1 residency followed by a PGY-2 psychiatry residency at the Chillicothe VA Medical Center in Chillicothe, Ohio. Dr. Palmer’s practice site is at North Kansas City Hospital (NKCH) in North Kansas City, Missouri, where she functions as the psychiatric pharmacist on a psychiatric consult liaison team. She treats a myriad of psychiatric conditions and substance use disorders. Research interests include student wellness, patient communication strategies, substance use disorders, and developmental disability. 




Presentation(s): 

Methamphetamine Use Disorder: A Review of the Pharmacologic Treatment 





 

 

By

Orns, Beth, MSW, LCSW


Beth is an alumni of the University of Missouri’s School of Social Work with 20 years of experience in the field.  Beth has practiced in a wide range of settings including community mental health center, not for profit agencies, inpatient psychiatric hospitals, private practice, and juvenile probation.  Areas where Beth has specialized include people with legal issues (both adults and adolescents), mental health issues, crisis evaluation and stabilization, and postpartum mental health issues.  Beth has served clients as a therapist, case manager, and as a manager.  Beth is an experienced public speaker and has presented on a wide range of topics in the community and at state and national conferences.  Beth previously founded and co-facilitated a postpartum mental health group in Columbia.

In the last several years Beth has developed a strong personal and professional interest in autism and it’s co-occurrence with mental health issues.  Beth currently serves as the parent advocate on the Mental Health/Crisis ECHO Autism Hub Team in Missouri.   She has worked with the Missouri Psychiatric Center and autism providers to enhance the care for patients with autism who are in the psychiatric hospital.  Beth also has presented on Mental Health and Autism in the community and at Easter Seals Annual conference in 2018.  Beth is passionate about helping providers for individuals with autism and providers in traditional mental health settings work together and learn more about how they can serve their clients with evidence based practices.



Presentation(s): 

Autism and Mental Health




 

 

By

Likcani, Adriatik, Ph.D.

Dr. Likcani holds a Ph.D. in Marriage and Family Therapy (MFT) from Kansas State University, two master’s degrees: MFT from University of Nebraska-Lincoln, and MSW from University of Missouri Kansas City, and a Post Graduate Certificate in Medical Family Therapy from the University of Nebraska Medical Center. Dr. Likcani is a Licensed Marital and Family Therapist (LMFT) in Missouri, Clinical Fellow with AAMFT, Alumni of the Minority Fellowship Program (MFP), and Chairperson of the State Committee of Marital and Family Therapists in Missouri.

Dr. Likcani has extensive experience with programs focused on treatment, prevention and recovery support. His research interests include: treatment for individuals with substance use disorders and their families; recovery courts; offender reentry; domestic violence; ethics; telehealth; diversity and cultural awareness; policy and advocacy. He is an Associate Professor at the University of Central Missouri and Program Director for the Marriage and Family Therapy graduate program.


Presentation(s): 


1. Contemporary Ethical Issues in Treatment and Recovery Support: Ethics, Values, Morals and Personal Worldview

2. Family Recovery Program: Development and Implementation

 


 

 

By

Leake, Jacalyn, MS, CCTP, CFTP

Jacalyn Leake graduated with a M.S. from the University of Central Missouri’s Human Development and Family Science, Marriage and Family Therapy masters program and is now attending a Couple and Family Therapy PhD program. Jacalyn previously received a B.A. in Psychology from Columbia College, is a Certified Clinical Trauma Professional, and a Certified Family Trauma Professional.

Jacalyn currently provides individual, family, and group therapy and psychoeducation for both residents and outreach clients at Survival Adult Abuse Center, Inc. as an MFT intern. At Survival House, Jacalyn designed, implemented, and facilitates two in-house solution focused therapy groups, one on communal living issues clients face and the other on progress and goals, as well as co-designed, implemented, and facilitates one in-house resilience and mindfulness-based group and a LGBTQ+ outreach support group. Jacalyn is an MFT  and is attending a Couple and Family Therapy PhD program.




Presentation(s): 


Trans and Gender Variant, Identity Development and Adverse Childhood Experiences


 

 

By

SOAR for Children: Building Resiliency & Supporting Families

Speaker(s):

Abigail Kirkman, MA

Daniel Coladonato

Milly Hall

Presentation: SSI/SSDI Outreach, Access, and Recovery (SOAR) for Children has proven to increase access to Supplemental Security Income (SSI) for children and youth with disabling conditions who are experiencing or at risk of homelessness. The curriculum emphasizes SSA work incentives that make it possible for youth to pursue vocational goals, while maintaining benefits. Learn how SOAR can be integrated into programming to ensure the right combination of services to best suit current and future needs.

Objectives:

  1. Define the importance of Supplemental Security Income (SSI) benefits for children and youth with serious mental illness and their families who are experiencing or at-risk of homelessness, including income, health insurance, education and employment supports, and housing stability
  2. Explain the effectiveness of the SSI/SSDI Outreach, Access, and Recovery (SOAR) model for expediting decisions and improving approval rates for Social Security disability benefits
  3. Identify opportunities to get involved with SOAR for children, including connecting to local SOAR efforts, the SOAR Online Course, and the SOAR Online Application Tracking (OAT) program
Kirkman_PPDownload